Live News Categoriesequity

Heron Therapeutics, Inc. (HRTX) News

Follow Heron Therapeutics, Inc. (HRTX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol HRTX Asset equity Sector Markets 90 days 1 Last 0.3437 Updated Sep 29, 2026, 09:03 PM UTC Open live news feed Open HRTX chart & news

L Heron Therapeutics Inks Multi-Product U.S. License With Long Grove, 10-Year Term Plus Renewals Heron Therapeutics entered a multi-product Development and License Agreement to commercialize certain products in the United States. The deal grants Heron an exclusive U.S. license to import, distribute, sell and market NEWS | Sep 29, 2026, 09:03 PM UTC